high risk breast cancer

Release time ：Dec-21,2024

High-risk breast cancer generally denotes breast cancer types with a higher likelihood of recurrence or mortality. These may encompass specific pathological types, molecular subtypes, or patients exhibiting certain unfavorable clinical characteristics.

In a detailed analysis, initial common factors include tumor size greater than 2 centimeters, positive lymph node metastasis, and high tumor cell grading, all of which correlate with an elevated risk of recurrence. Additionally, certain pathological types such as triple-negative and HER2-positive breast cancers are categorized as high risk due to their typically poor response to treatments and higher recurrence potential. Moreover, patient age, genetic predispositions (e.g., BRCA gene mutations), and the molecular subtypes of the tumor are crucial for assessing breast cancer risk.

For patients diagnosed with high-risk breast cancer, it is advised to seek immediate medical attention and adhere to the treatment recommendations provided by their healthcare providers. Treatment options may encompass surgery, radiotherapy, chemotherapy, and targeted therapies specific to molecular subtypes. Patients should also engage in regular follow-ups and monitoring to detect and address any potential recurrence or metastasis early on. Throughout treatment, maintaining a positive attitude, actively cooperating with the treatment plan, and adjusting lifestyle factors such as diet and exercise can enhance treatment outcomes and overall quality of life.